Detected ·

Freenome

——

Freenome (Nasdaq: FRNM) begins trading on Nasdaq today. The early cancer detection company went public through a business combination, gaining capital to advance its multiomic blood-based cancer screening tests, AI/ML-driven platform, and future product launches including SimpleScreen CRC currently under FDA review.

Amount
—
Stage
—
Event
Funding round
Detected
2026-07-27 16:05:58 UTC
Signal ID
95c97d64-d6e4-45ca-82b6-716b605e0cdc

As the API returns it

{
  "id": "95c97d64-d6e4-45ca-82b6-716b605e0cdc",
  "created_at": "2026-07-27T16:05:58.726106Z",
  "company_name": "Freenome",
  "company_website_url": "www.freenome.com",
  "company_linkedin_url": "https://www.linkedin.com/company/freenome",
  "event_type": "funding",
  "funding_amount": null,
  "funding_currency": null,
  "funding_stage": null,
  "message": "*Freenome (Nasdaq: FRNM) begins trading on Nasdaq today. The early cancer detection company went public through a business combination, gaining capital to advance its multiomic blood-based cancer screening tests, AI/ML-driven platform, and future product launches including SimpleScreen CRC currently under FDA review.*"
}